Amitivir sodium

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmitivir sodium
Drug Alias NameLY-253963
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsParamyxoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus InfectionsParamyxoviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A